Newsletter | June 16, 2026

06.16.26 -- From Biologics To Combination Products: Explore CDMO Capabilities

 

 

As biologics, cell and gene therapies, and other advanced therapeutics transform drug development, success depends on more than the molecule. Sponsors must navigate complex manufacturing processes, evolving delivery technologies, stringent regulatory requirements, and the challenge of scaling innovative therapies without compromising quality or patient experience.

 

This edition of the Outsourced Pharma Capabilities Update (OPCU) brings together expertise across biologics manufacturing, advanced therapies, drug delivery, and combination products. Watch the presentations below to explore the capabilities, technologies, facilities, and expertise driving the next generation of advanced therapeutics from development through commercialization.

 

Recent Sessions Available On-Demand         
Fill/Finish & Small Molecule – 4/21/2026 & 4/22/2026     

 

Upcoming OPCU Topics & Times

Cell Therapy | 6/16/2026, AM Session         
Cell Line Development | 6/16/2026, PM Session       
Microbial Development & Manufacturing | 6/17/2026, AM Session       
ADCs | 6/17/2026, PM Session   

 

Access more on-demand OPCU recordings and upcoming sessions here.

LARGE MOLECULE

Alcami

Learn how shear studies, filling simulations, and scale-down TFF models improve tech transfer, enhance robustness, and reduce aggregation and interfacial stress across multiple dosage formats.

Request Information

Alcami

Rentschler Biopharma

Witness how we combine deep process development expertise, advanced manufacturing tech, and regulatory support to accelerate biopharmaceutical programs and drive reliable results.

Request Information

Rentschler Biopharma

Rezon Bio

Discover how tailored biologics development strategies can improve scalability, reduce tech transfer risk, and create more reliable pathways from early development to commercial supply.

Request Information

Rezon Bio

Resilience, LLC.

An integrated network unites biologics, cell therapy, and drug product with digital systems and teams to speed tech transfer, scale reliably, and ensure delivery from development to commercial.

Request Information

Resilience, LLC.

Samsung Biologics

Watch this on-demand session to explore the future of global biologics manufacturing, dual-sourcing strategies, and next-generation expansion plans in advanced therapies.

Request Information

Samsung Biologics

COMBINATION PRODUCTS & DRUG DELIVERY

Nanoform

See how novel nanoforming technologies can enable alternative delivery routes and support high-concentration injectable and pulmonary formulation development beyond traditional approaches.

Request Information

Nanoform

PCI Pharma Services

Explore the capabilities, infrastructure, and innovations driving scalable clinical-to-commercial solutions for today’s increasingly complex injectable combination products.

Request Information

PCI Pharma Services